Outset Medical Inc.
OM | NASDAQ
$3.16
+$0.04 (+1.28%)
Sep 22, 2026, 9:55 AM ET · Market open
Market Data
Market Cap $57.84M
Enterprise Value $-82.56M
Beta 1.90
Average Volume 194.1K
Shares Outstanding (Diluted) 18.62M
Shares Change YoY 4.94%
Institutional Ownership 80.45%
Exchange NASDAQ
ISIN US6901452069
Price Performance
Price Change 1M -25.9%
Price Change 3M -34.5%
Price Change 6M -11.6%
Price Change YTD -15.7%
Price Change 1Y -80.2%
Price Change 3Y -98.1%
Price Change 5Y -99.6%
1M CAGR (ann.) -36.3%
1Y CAGR (ann.) -78.0%
5Y CAGR (ann.) -66.6%
All-Time CAGR -61.0%
Valuation
PE Ratio -0.76
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.03
PS Ratio 0.49
Forward PS 0.40
PB Ratio 0.60
P/FCF Ratio -1.12
P/Adj. FCF Ratio -0.82
P/OCF Ratio -1.51
EV/Sales -0.70
EV/EBIT 1.38
EV/EBITDA 1.47
EV/FCF 1.59
Earnings Yield -131.1%
FCF Yield -89.5%
Adj. FCF Yield -122.0%
Financial Health
Net Cash $140.39M
Total Debt $6.8M
Cash & Short-Term Investments $147.19M
Total Assets $242.39M
Current Ratio 5.19
Quick Ratio 4.11
Debt / Equity Ratio 1.08
Debt / EBITDA -0.12
Debt / FCF -0.13
OCF / Debt -7.52
Interest Coverage -4.81
Altman Z-Score -6.16
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 41.8%
Operating Profit Margin -56.1%
EBITDA Margin -47.7%
Net Profit Margin -63.1%
FCF Margin -44.0%
Adj. FCF Margin -59.9%
SBC / Revenue 13.0%
SBC Impact (per share) -36.2%
Returns
Return on Assets -30.6%
Return on Equity -62.3%
Return on Invested Capital -32.8%
Return on Capital Employed -33.3%
Return on Tangible Assets -30.6%
Historical Growth (CAGR)
Revenue CAGR 3Y -3.0%
Revenue CAGR 5Y 8.3%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 56.2%
EPS CAGR 5Y -19.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y 50.9%
FCF CAGR 5Y 23.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 23.1%
Revenue Growth Next 3Y 13.6%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.69
EPS Growth Est (next Q) 0.5%
Revenue Est (next Q) $31.4M
Revenue Growth Est (next Q) 6.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $14
Price Target Upside 348.7%
Cash Flow
Operating Cash Flow $-51.16M
Free Cash Flow $-51.79M
Adj. Free Cash Flow $-70.53M
FCF Per Share -$2.09
OCF Per Share -$2.06
OCF/S Ratio -32.5%
Income Statement
Revenue $117.8M
Gross Profit $49.2M
Operating Income $-66.04M
EBITDA $-56.21M
Net Income $-74.29M
EPS (Diluted) -$4.09
Revenue / Employee $380.01K
Profit / Employee $-239.65K
Employees 310
Add to Watchlist
Select watchlists to add or remove OM